- Q1 2024 Bioatla Inc Earnings Call TranscriptMay 14, 2024$2.61 (-1.14%)Earnings
- Q4 2023 Bioatla Inc Earnings Call TranscriptMar 26, 2024$3.01 (+29.18%)Earnings
- Bioatla Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Bioatla Inc R&D Day TranscriptDec 13, 2023
- Q3 2023 Bioatla Inc Earnings Call TranscriptNov 07, 2023$1.76 (-4.35%)Earnings
- Bioatla Inc at HC Wainwright Investment Conference - New York(Pre Recorded) TranscriptSep 11, 2023
- Bioatla Inc at HC Wainwright Immune Cell Engager Virtual Conference TranscriptAug 17, 2023
- Q2 2023 Bioatla Inc Earnings Call TranscriptAug 01, 2023$2.88 (-3.68%)Earnings
- Bioatla Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Bioatla Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Bioatla Inc Earnings Call TranscriptMay 11, 2023$3.21 (-3.02%)Earnings
- Q4 2022 Bioatla Inc Earnings Call TranscriptMar 23, 2023$2.3 (-1.71%)Earnings
- Q3 2022 Bioatla Inc Earnings Call TranscriptNov 03, 2022$6.36 (-1.40%)Earnings
- Q2 2022 Bioatla Inc Earnings Call TranscriptAug 09, 2022$3.61 (-3.48%)Earnings
- Q1 2022 Bioatla Inc Earnings Call TranscriptMay 04, 2022$4.08 (+6.53%)Earnings
Q2 2022 Bioatla Inc Earnings Call Transcript
Hello and welcome to the BioAtla second-quarter 2022 earnings call. (Operator Instructions) Please note today's event is being recorded. I now like to turn the conference over to your host today, Bruce Mackle. Mr. Mackle, please go ahead.
Thank you, operator, and good afternoon, everyone. With me today on the phone from BioAtla are Dr. Jay Short, Chairman, CEO, and Co-Founder; Scott Smith, President; Philippe Martin, Chief of Clinical Development and Operations; Sheri Lydick, Senior Vice President, Commercial Strategy; and Richard Waldron, Chief Financial Officer. Earlier this afternoon, BioAtla released financial results and a business update for the quarter ended June 30, 2022. A copy of the press release is available on the company's website.
Before we begin, I'd like to remind everyone that statements made during this conference call will include forward-looking statements, including, but not limited to, statements regarding BioAtla's business plans and prospects, financial and operating performance and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)